L’Oréal Shares Drop Amid China Slowdown: What’s Next for the Beauty Giant?

L’Oréal, the world’s largest beauty company, has started 2025 on shaky ground. On February 7, the company’s stock took a significant hit, declining by over 4% after reporting weaker-than-expected quarterly sales growth. The primary culprits? Weakened consumer demand in China and North America, two of L’Oréal’s key markets.

This unexpected slowdown has investors questioning whether the company is facing a temporary dip or a larger structural challenge in the global beauty industry.

Stock Performance: A Tough Start to 2025

L’Oréal’s stock decline made headlines, dropping 3.9% by 08:08 GMT, placing it among the biggest losers in European equity markets. The disappointing performance in China and North America has raised concerns, as both regions play a critical role in L’Oréal’s overall growth strategy.

Sales Growth Misses Expectations

The beauty giant reported a 2.5% increase in fourth-quarter sales, significantly below analysts’ estimates of 4% growth. This marks L’Oréal’s slowest quarterly growth since 2020, a period impacted by the COVID-19 pandemic.

China and North America: Markets Losing Momentum

The company’s struggles in China were especially pronounced. Sales in North Asia, which includes China, fell by 3.6%, following a 6.5% decline in the prior quarter. According to L’Oréal’s CFO, Christophe Babule, the market failed to stabilize toward the end of 2024, despite hopes for recovery.

North America also showed signs of slowing down. Quarterly sales growth dropped to 1.4%, compared to 5.2% in the third quarter of 2024. With both China and the U.S. underperforming, concerns about L’Oréal’s ability to sustain long-term growth have intensified.

Luxury and Skincare Divisions Struggle

The Luxe division, which includes high-end brands like Yves Saint Laurent and Valentino, failed to meet expectations, missing growth targets by 4 percentage points.

Additionally, L’Oréal’s dermatological skincare business—once a strong performer—also faltered. Barclays analysts noted that the division’s slowdown contributed significantly to the earnings miss, raising concerns about whether this is a short-term issue or a deeper problem within the company’s portfolio.

Strategic Moves: Seeking New Growth Opportunities

Despite the challenges, L’Oréal is actively working on strategies to boost future growth.

A High-Profile Partnership with Jacquemus

One of the company’s most notable moves is a partnership with Jacquemus, a French luxury fashion brand. Under the deal, L’Oréal will develop and distribute beauty products for Jacquemus, while also acquiring a minority stake in the company. This step reinforces L’Oréal’s commitment to expanding its luxury portfolio.

Potential Sale of Sanofi Shares

Another strategic consideration for L’Oréal is the possible sale of its stake in pharmaceutical giant Sanofi. CFO Christophe Babule suggested that such a move could unlock capital for future acquisitions, signaling that the company might focus more on luxury and skincare investments.

What Are Analysts Saying?

Market experts remain cautious about L’Oréal’s near-term prospects, especially given China’s sluggish economic recovery and ongoing weaknesses in the dermatological division.

Barclays analysts have warned that if growth does not rebound soon, investors may start questioning whether this is just a temporary slowdown or a sign of deeper structural issues.

Final Thoughts: Can L’Oréal Overcome the Slowdown?

L’Oréal continues to be a dominant force in the global beauty industry. However, its recent slowdown in China and North America raises pressing concerns about its future growth trajectory.

The company’s partnership with Jacquemus and the potential restructuring of its investment portfolio suggest an active approach to navigating market challenges. However, for investor confidence to fully recover, L’Oréal must find ways to reignite demand in key regions.

Will 2025 be the year L’Oréal regains momentum, or are these setbacks just the beginning of a more challenging period for the company? Only time will tell.